1. NAMING A DRUG WHY THE FUSS?

2. READING A SCRIPT Survey says…  Plendil  Isordil

3. USE A PDR—PLENDIL OR ISORDIL  WHAT ARE THEY FOR?  RISKS? On June 23, 1995, Ramon Vasquez received the preceeding prescription from his cardiologist. He began taking the medication given to him by the pharmacist on a Saturday morning. By Sunday night, the medication had affected his heart so much that he had a heart attack. He died several days later.

4. Another one… Is it…  Avandia  Coumadin

5. WHY THE FUSS? USE A PDR— Avandia or Coumadin WHAT ARE THEY FOR? RISKS?

6. NAMING A DRUG A marketed drug has three names: a chemical name, a generic name, and a brand name. Chemical Name  The chemical name is the scientific name based on the compound's chemical structure  The chemical name is almost never used when the drug goes to market  The chemical name is usually used by scientists and other researchers only.  N-acetyl-para-aminophenol

7. NAMING A DRUG Generic Name  The generic name is granted by the USAN Council (United States Adopted Names Council) and is commonly used to identify a drug during its useful clinical lifetime  Acetaminophen

8. NAMING A DRUG Brand Name  The company that patents the drug creates the brand name (trademark)  This name identifies the drug during the 17 years that the company has exclusive rights to make, sell, and use it under patent law  Tylenol

9. NAMING A DRUG The process for naming a marketable drug involves five steps: 1. NCE (new chemical entity) submission and patent application 2. Generic naming 3. Brand naming 4. FDA review 5. Final approval

10. NAMING A DRUG- the chemical name A pharmaceutical company submits data on a newly discovered compound to FDA for classification as a new chemical entity to gain permission for animal testing to determine any desirable and undesirable effects. The chemical name is not pre-approved by any organization, nor is it recognized in any standard manuals, such as USP publications Taking two years on average

11. NAMING A DRUG-the generic name The USAN Council grants generic name to an entity that appears to have potential as a drug The USAN Council  Representative from the Food and Drug Administration (FDA)  Representative from the American Pharmaceutical Association (APhA),  Representative from the American Medical Association (AMA)  Representative from the USP

12. NAMING A DRUG-the generic name After approval by the USAN Council, the name is sent to the World Health Organization for final approval. At this point, the company begins animal testing for efficacy and toxicity. The generic name is usually found in the originating country's pharmacopeia, an official book or list of drugs and medicines and the standards established for their production, dispensation, and use.

13. NAMING A DRUG-the generic name USAN Council has several criteria for a generic name  appropriate for the drug  short, easy to pronounce, and euphonic  suitable for routine use both in the United States and internationally.  The name cannot be misleading or confusing or imply efficacy or application to particular anatomical parts.

14. NAMING A DRUG-the generic name Generic names are coined using an established stem, or group of letters, that represents a specific drug class. USAN stems include prefixes like -coxib for arthritis medications -celecoxib, valdecoxib, and rofecoxib are generic names containing the stem. Each belongs to a class of drugs known as the COX-2 inhibitors.celecoxibvaldecoxib rofecoxib

15. NAMING A DRUG-the generic name Names that include such stems, chemistry roots, or any other coded information are easier to remember, and give clues about what a drug is used for. These names, however, typically sound or look so much alike that they contribute to medication errors, especially if the products share common dosage forms and other similarities.

16. NAMING A DRUG-the brand name The brand name, also called trademark, can be created as soon as a generic name has been established. According to a report in the January-February 2004 issue of the Journal of the American Pharmacists Association, there are more than 9,000 generic drug names and 33,000 trademarked brand names in use in the United States

17. NAMING A DRUG-the brand name To minimize confusion between drug names that look or sound alike, the FDA reviews about 400 brand names a year before they are marketed. About one-third are rejected. Read the article: “When a Drug Maker Creats a New Pill, Uncle Sam Vets Name”, and describe how the FDA approves the final brand name.

18. Two Compendia of Drug Informaton and Formulation http://www.usp.org/aboutUSP/whatsNew.html US Pharmacopia –Dosage, Monographs (Each monograph includes information on pricing, adverse reactions, contraindications, pharmacokinetics as well as related drug monograph topics: dissolution rates.) NF--An excipient is an inactive substance used as a carrier for the active ingredients of a medication.

20. Unofficial Sources of Drug Information Merck Index:The Merck Index OnlineSM is the online version of the monographs in the printed 13th Edition of The Merck Index (a U.S. publication, Whitehouse Station, N.J., USA), an internationally recognized, one-volume encyclopedia of chemicals, drugs, and biologicals. Each monograph in the encyclopedia (each record in the database) discusses a single chemical entity or a small group of very closely-related compounds. Updates contain material not yet available in print. PDR:The Physicians' Desk Reference (PDR) is a commercially published compilation of manufacturers' prescribing information (package insert) on prescription drugs, updated annually. While designed to provide physicains with the full legally mandated information relevant to writing prescriptions (just as its name suggests), it is widely available in libraries and bookstores, widely used by other medical specialists, and in significant part valuable to consumers.